INMB earnings: a negative outcome, -18.4%

On March 4, 2021, INmune Bio, Inc. reached its earnings. The result was a negative outcome, and the stock moved -18.4% in the window around the event. It had already run -18.5% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.